Related Experiment Videos
FDA perspective on anti-TNF treatments
1Immunology and Infectious Disease Branch, Division of Clinical Trial Design and Analysis, Food and Drug Administration, 1401 Rockville Pike, Rockville, MD 20852, USA.
Annals of the Rheumatic Diseases
|December 1, 1999
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent.
The New England journal of medicine·2001
Studies of marrow progenitor abnormalities in lupus-prone mice. II. Further studies of NZB Thy 1(neg)Lin(neg) bone marrow cells.
Clinical immunology and immunopathology·1994
Low-dose blinatumomab in multidrug-resistant rheumatoid arthritis-a case series.
Annals of the rheumatic diseases·2026
Spatially distinct macrophage subsets drive myofibroblast heterogeneity and maladaptive fibrosis in lupus nephritis.
Annals of the rheumatic diseases·2026
Shared genetic architecture and therapeutic targets across paediatric immune-mediated diseases.
Annals of the rheumatic diseases·2026
Placental pathology in stillbirth.
Pathology·2026
Diagnostic Twists and Turns: Spotting an Isolated Fallopian Tube Torsion.
Ultrasound quarterly·2026
Cardiac Biomarkers and Pregnancy-Associated Cardiovascular Disease.
Current cardiology reports·2026
Miscarriage Trends and Blood Group Associations During the COVID-19 Pandemic: A Comparative Study in Ramsar, Iran.
Iranian journal of nursing and midwifery research·2026